Generics Industry News Search
 |
|
|
|
|
|
|
June 2004 News Archive |
|
|
| |
|
Vienna, June 7, 2004 - Sandoz, a Novartis company, today announced plans to acquire Sabex Holdings Ltd. in a USD 565 million cash transaction that will provide strong growth opportunities in injectable generics and new entry into the Canadian generics sector. The deal continues Sandoz strategy of building its global business through strong organic growth and strategic acquisitions that provide access to new geographic markets, therapeutic lines, formulations and production capabilities....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Basel, 8 June 2004: Roche's discounted pricing applicable to 85% of people in the world living with HIV/AIDS. Today Roche announced further significant reductions in the prices of its HIV protease inhibitors, Invirase (saquinavir) and Viracept (nelfinavir), ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Wednesday, June 9, 2004 ROCHESTER, N.Y.: Bausch & Lomb has received U.S. Food and Drug Administration approval of the Company's Abbreviated New Drug Application (ANDA) to manufacture and sell ciprofloxacin ophthalmic solution USP, 0.3%, indicated for use in treating bacterial eye infections including conjunctivitis (commonly known as pinkeye) and corneal ulcers....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
LAURELTON, NY, June 9, 2004: Eon Labs, Inc. announced today that it received final approval for Ciprofloxacin, 250mg, 500mg and 750mg tablets. Eon Labs' Ciprofloxacin 100mg tablets remains tentatively approved and will be eligible for final approval after a 180-day exclusivity period expires....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
DUBLIN, June 10, 2004: Elan Corporation, plc announced today that it has entered into a manufacturing and supply agreement with Eli Lilly and Company (Lilly) under which Elan will supplement Lilly's manufacture of duloxetine hydrochloride capsules ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jacksonville, FL - June 10, 2004: Ranbaxy Pharmaceuticals Inc. (RPI), announced today that RLL had received final approval from the U.S. Food and Drug Administration, Office of Generic Drugs, to manufacture and market Ciprofloxacin ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Corona, June 16, 2004: Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today the issuance by the United States Patent and Trademark Office of patent number 6,743,441, entitled Compositions and Methods for Minimizing Adverse Drug Experiences Associated with Oxybutynin Therapy....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jerusalem, June 18, 2004:Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the company's ANDA for Metformin HCl Extended-Release Tablets, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
EXETER, June 21: Bentley Pharmaceuticals, Inc. a specialty pharmaceutical company focused on advanced drug- delivery technologies, which also manufactures and markets generic and branded products in Europe, announced today that three of its subsidiaries have been granted approval by the Spanish Ministry of Health to market generic equivalents of lansoprazole in Spain...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
FORT LAUDERDALE, June 21, 2004: Andrx Corporation today announced that the United States Food and Drug Administration has issued an approvable letter for Pfizer Inc.'s New Drug Application for Cardura(R) XL, a sustained-release formulation of doxazosin mesylate, used to treat benign prostatic hyperplasia (BPH)....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jacksonville, FL - June 22, 2004: Ranbaxy Pharmaceuticals Inc. announced today that RLL has received final approval from the U.S. Food and Drug Administration to market Metformin Hydrochloride Extended-release Tablets, 500 mg....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
WASHINGTON, June 23: The Generic Pharmaceutical Association (GPhA) today called the Senate Judiciary Committee hearing on generic biopharmaceuticals a significant movement toward saving American consumers billions of dollars on these drug products. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PITTSBURGH, June 24: Mylan Laboratories Inc. today announced that the U.S. Food and Drug Administration has granted final approval for Mylan Pharmaceuticals Inc.'s Abbreviated New Drug Application for Levothyroxine Sodium Tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
FORT LAUDERDALE, June 25, 2004: Corporation today announced that the United States Food and Drug Administration has approved the Company's abbreviated new drug application for Clarithromycin Extended-release Tablets, 500mg, an antibiotic which is bioequivalent to Abbott Laboratories Inc.'s Biaxin(R) XL Filmtab(R)....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
USA, June 25: The legal disputes between SCHWARZ PHARMA's KUDCo, Mylan and related parties have been settled, eliminating legal uncertainties with regard to generic omeprazole. SCHWARZ PHARMA is confirming its outlook for 2004....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
California, Jun 28, 2004 Watson Pharmaceuticals, Inc, a leading specialty pharmaceutical company, announced today that following an extensive strategic and operational review of its business, the Company is refocusing its product development and sales and marketing resources to concentrate on three core business areas: urology, nephrology and generics....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
NEW YORK, June 30, 2004: Pfizer, Inc said today it has prevailed in a patent infringement suit in which Teva Pharmaceuticals USA Inc. was seeking approval to sell a generic version of Pfizer's blood pressure medicine Accupril (quinapril hydrochloride)....
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
